<--- Back to Details
First PageDocument Content
Renal cell carcinoma / Kidney / Cancer / Transitional cell carcinoma / Treatment and prognosis of renal cell carcinoma / Renal medullary carcinoma / Medicine / Oncology / Kidney cancer
Renal cell carcinoma
Kidney
Cancer
Transitional cell carcinoma
Treatment and prognosis of renal cell carcinoma
Renal medullary carcinoma
Medicine
Oncology
Kidney cancer

Kidney Cancer Update 2011

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 4,21 MB

Share Document on Facebook

Similar Documents

POSTER SESSION 1: NEOPLASMS. VARIA. Exhibition area, 7 May, 09.00 – 12.00 h Chairperson: Radko Radev (Varna), Secretary: Vessela Uzunova (Sofia) 1. The therapy of the advanced renal cell carcinoma – new agents and st

POSTER SESSION 1: NEOPLASMS. VARIA. Exhibition area, 7 May, 09.00 – 12.00 h Chairperson: Radko Radev (Varna), Secretary: Vessela Uzunova (Sofia) 1. The therapy of the advanced renal cell carcinoma – new agents and st

DocID: 1uMwb - View Document

Assessment RunPAX8 Material The slide to be stained for PAX8 comprised: 1. Fallopian tube, 2. Tonsil, 3. Kidney, 4. Renal clear cell carcinoma,

Assessment RunPAX8 Material The slide to be stained for PAX8 comprised: 1. Fallopian tube, 2. Tonsil, 3. Kidney, 4. Renal clear cell carcinoma,

DocID: 1uiGA - View Document

· RENAL CELL CARCINOMA ·  Biomarkers for Renal Cell and Urothelial Carcinoma Nazli Dizman, MD, Joann Hsu, BS, Paulo Bergerot, MD, Manuel Caitano Maia, MD, and Sumanta K. Pal, MD  Keywords: Biomarkers, renal cell carcin

· RENAL CELL CARCINOMA · Biomarkers for Renal Cell and Urothelial Carcinoma Nazli Dizman, MD, Joann Hsu, BS, Paulo Bergerot, MD, Manuel Caitano Maia, MD, and Sumanta K. Pal, MD Keywords: Biomarkers, renal cell carcin

DocID: 1sTBk - View Document

www.edoriumjournals.com  CASE REPORT PEER REVIEWED | OPEN ACCESS

www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

DocID: 1qNSk - View Document

sorafenib clinical trial risks of sorafenib sorafenib gastric cancer. sorafenib agent sorafenib pulmonary risks sorafenib lung cancer sorafenib dosage

sorafenib clinical trial risks of sorafenib sorafenib gastric cancer. sorafenib agent sorafenib pulmonary risks sorafenib lung cancer sorafenib dosage

DocID: 1qmZp - View Document